Massachusetts' biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.
Construction Employment
Union Labor & Earnings, 2015-20
Pharmaceutical & Biotech
Massachusetts Construction Labor Hours by Trade
Pharmaceutical & Biotech, 2015-20
99,084
Installation
22,903
Maintenance
121,988
Total hours
Largest Construction Projects
Pharmaceutical & Biotech Manufacturing, 2015-20
Vertex Pharmaceuticals Incorporated
Boston Brownfield Innovation Square ISQ Cell and Gene Therapies Plant
Boston, MA
$185,000,000
2020-2021
Novartis Institutes for Biomedical Research
Cambridge Vaccine and Diagnostics R&D Center Expansion
Cambridge, MA
$600,000,000
2012-2015
Bristol-Myers Squibb Company
Devens Biologics Plant Expansion
Devens, MA
$350,000,000
2020-2023
Sanofi Genzyme Corporation
Allston Cell Culture Plant Facilities Equip Upgrade/Renovation ("Project Rena")
Allston, MA
$200,000,000
2012-2015
Alnylam Pharmaceuticals Incorporated
Norton Grassroot RNAI-Based Therapeutics Plant
Norton, MA
$200,000,000
2016-2019
Pfizer Incorporated
Andover Biotherapeutics, Bulk Pharmaceuticals & APIS Plant Addition
Andover, MA
$200,000,000
2016-2019
Bristol-Myers Squibb Company
Devens, MA, USA
Devens Biologics and Cell Culture Plant Cell Therapy Facility (CTF) Phase 3 Add
Devens, MA
$350,000,000
2020-2023
Foundation Medicine Incorporated
Boston, MA, USA
Boston Grassroot Genomic Diagnostic Laboratory
Boston, MA
$300,000,000
2020-2023
Sanofi Genzyme Corporation
Cambridge, MA, USA
Cambridge Genetic Rare Disease Research + Development Building Addition Parcel H
Cambridge
$293,000,000
2019-2021
Vertex Pharmaceuticals Incorporated
Boston Brownfield Innovation Square ISQ Cell and Gene Therapies Plant
Boston, MA
Location
$185,000,000
Project Value
2020-2021
Years
Vertex Pharmaceuticals Incorporated
Boston Brownfield Innovation Square ISQ Cell and Gene Therapies Plant
Novartis Institutes for Biomedical Research
Cambridge Vaccine and Diagnostics R&D Center Expansion
Bristol-Myers Squibb Company
Devens Biologics Plant Expansion
Boston, MA
Location
$185,000,000
Project Value
2020-2021
Years
Cambridge, MA
Location
$600,000,000
Project Value
2012-2015
Years
Devens, MA
Location
$350,000,000
Project Value
2020-2023
Years
Sanofi Genzyme Corporation
Allston Cell Culture Plant Facilities Equip Upgrade/Renovation ("Project Rena")
Alnylam Pharmaceuticals Incorporated
Norton Grassroot RNAI-Based Therapeutics Plant
Pfizer Incorporated
Andover Biotherapeutics, Bulk Pharmaceuticals & APIS Plant Addition
Allston, MA
Location
$200,000,000
Project Value
2012-2015
Years
Norton, MA
Location
$200,000,000
Project Value
2016-2019
Years
Andover, MA
Location
$200,000,000
Project Value
2016-2019
Years
Bristol-Myers Squibb Company
Devens Biologics and Cell Culture Plant Cell Therapy Facility (CTF) Phase 3 Add
Foundation Medicine Incorporated
Boston Grassroot Genomic Diagnostic Laboratory
Sanofi Genzyme Corporation
Cambridge Genetic Rare Disease Research + Development Building Addition Parcel H
Devens, MA
Location
$350,000,000
Project Value
2020-2023
Years
Boston, MA
Location
$300,000,000
Project Value
2020-2023
Years
Cambridge
Location
$293,000,000
Project Value
2019-2021
Years
Vertex Pharmaceuticals Incorporated
Boston Brownfield Innovation Square ISQ Cell and Gene Therapies Plant
Boston, MA
Location
$185,000,000
Project Value
2020-2021
Years
Novartis Institutes for Biomedical Research
Cambridge Vaccine and Diagnostics R&D Center Expansion
Cambridge, MA
Location
$600,000,000
Project Value
2012-2015
Years
Bristol-Myers Squibb Company
Devens Biologics Plant Expansion
Devens, MA
Location
$350,000,000
Project Value
2020-2023
Years
Sanofi Genzyme Corporation
Allston Cell Culture Plant Facilities Equip Upgrade/Renovation ("Project Rena")
Allston, MA
Location
$200,000,000
Project Value
2012-2015
Years
Alnylam Pharmaceuticals Incorporated
Norton Grassroot RNAI-Based Therapeutics Plant
Norton, MA
Location
$200,000,000
Project Value
2016-2019
Years
Pfizer Incorporated
Andover Biotherapeutics, Bulk Pharmaceuticals & APIS Plant Addition
Andover, MA
Location
$200,000,000
Project Value
2016-2019
Years
Bristol-Myers Squibb Company
Devens Biologics and Cell Culture Plant Cell Therapy Facility (CTF) Phase 3 Add
Devens, MA
Location
$350,000,000
Project Value
2020-2023
Years
Foundation Medicine Incorporated
Boston Grassroot Genomic Diagnostic Laboratory
Boston, MA
Location
$300,000,000
Project Value
2020-2023
Years
Sanofi Genzyme Corporation
Cambridge Genetic Rare Disease Research + Development Building Addition Parcel H
Cambridge
Location
$293,000,000
Project Value
2019-2021
Years
